Home
AI
World
Politics
Health
Crime & justice
Science & technology
Social issues
Sports
Money
Entertainment
Environment/energy
Military
Culture
Weather
Media






Home
Bias Split
Public FiguresControversies

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters

Sign Up!
Sign Up Now!

How our sliders workAboutContact UsNewsletter Archive
MediaFAQGlossaryPrivacy Policy
  1. Home

FDA Recalls Over 500K COVID Tests Over Bacteria Risk

  • #Medicine & healthcare
  • #COVID-19
  • #Testing
  • #Insurance
  • #Health insurance & managed care
  • #Finance
FDA Recalls Over 500K COVID Tests Over Bacteria Risk
story
MAY 2023
Image copyright: usatoday
story last updated FEB 2024

The Spin

Establishment-critical narrative

The recall exposes the flaws in the FDA's approval program, which allowed defective or contaminated COVID test kits to remain on the shelves for too long after approval, potentially allowing people with false negative results to have unknowingly infected others. The agency must tighten its quality control efforts and ensure such dangerous mishaps don't arise again.

Wall Street Journal

Pro-establishment narrative

At-home COVID tests were never expected to be as sensitive, perfect, or fool-proof as the PCR tests performed in a lab or clinic for detecting infection. While the bacteria contamination is concerning, the FDA caught the issue early on and must continue to advance greater access to at-home COVID testing to best support public health needs.

NPR Online News

Metaculus Prediction


Articles on this story

Here's why Medicaid coverage and free COVID tests, treatments will soon change
USA TodayAUG 2023
Millions Could Lose Medicaid Coverage When Pandemic Health Emergency Ends
Wall Street JournalAUG 2023